Effect of Elastic Therapeutic Taping on Post-Sternotomy Pain in Coronary Artery Bypass Graft Surgery
The Effectiveness of Elastic Therapeutic Taping in Pain Management After Sternotomy: A Randomized Controlled Double-Blind Study in Patients Undergoing Coronary Artery Bypass Grafting Surgery
1 other identifier
interventional
195
1 country
1
Brief Summary
This research study aims to find out whether elastic therapeutic taping can help reduce pain after heart surgery, specifically coronary artery bypass grafting (CABG), which is done using a surgical cut through the breastbone (sternotomy). This type of surgery often causes pain that makes it hard for patients to breathe deeply, move around, or recover quickly. Managing this pain in a safe and effective way is important for better healing and quality of life. Elastic therapeutic taping is a method where special stretchy tape is applied to the skin to reduce pain and support the muscles. It is already used for other conditions like back or shoulder pain. In this study, researchers want to see if this taping method can also help people recover better after heart surgery by lowering pain, helping movement, and improving sleep and emotional well-being. A total of 195 participants who had planned (elective) CABG surgery will be included in the study. People will be placed into one of three groups: One group will get real elastic tape applied near the surgical area. One group will get fake (placebo) tape that looks the same but has no medical effect. One group will get a different kind of supportive treatment in other body areas. Neither the patients nor the people measuring the results will know which group each person is in. This is called a "double-blind randomized controlled trial," which is the best way to get reliable results. The researchers will check each participant's pain levels using a visual scale, and will also look at other things like oxygen levels, sleep quality, anxiety, how well they move, and how much pain medicine they use. These checks will happen several times in the first two days after surgery. The taping is safe and non-invasive. Some people may experience mild skin irritation, but no serious side effects are expected. Participation is voluntary, and people can leave the study at any time. No payments will be made to participants, and all medical services related to the study will be free of charge. This study is supported by Bolu Abant Izzet Baysal University. The results may help offer a new, drug-free option for managing pain after heart surgery and may improve patients' recovery experience.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2025
CompletedFirst Submitted
Initial submission to the registry
March 25, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2025
CompletedDecember 31, 2025
December 1, 2025
11 months
March 25, 2025
December 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity (Visual Analog Scale - VAS)
Change in pain intensity will be assessed using the Visual Analog Scale (VAS), a 100 mm horizontal line where participants rate their pain from 0 (no pain) to 100 (worst imaginable pain).
Baseline, 12 hours, 24 hours, and 48 hours after intervention
Secondary Outcomes (9)
Oxygen Saturation (SpO₂)
Baseline, 12 hours, 24 hours, and 48 hours after intervention
Sleep Quality (VAS)
Baseline, 24 hours, and 48 hours after intervention
Anxiety Level (VAS)
Baseline, 12 hours, 24 hours, and 48 hours post-intervention
Functional Mobility (Timed Up and Go Test)
Baseline, 12 hours, 24 hours, and 48 hours after intervention
Analgesic Use
0-48 hours post-intervention
- +4 more secondary outcomes
Study Arms (3)
Elastic Therapeutic Taping Group
EXPERIMENTALParticipants in this group will receive elastic therapeutic taping (kinesio taping) applied bilaterally 3 cm lateral to the sternotomy incision site. The tape will be applied with standardized tension and technique by a trained physiotherapist within 24 hours post-CABG surgery. The tape will remain in place for 48 hours. The goal is to assess the therapeutic effect of kinesio taping on postoperative pain and related outcomes.
Placebo Taping Group
PLACEBO COMPARATORParticipants in this group will receive placebo taping to the same area (3 cm lateral to the sternotomy incision), using the same type of tape but without any tension or therapeutic intent. The tape will be applied by the same trained team, in an identical manner visually, but with no mechanical stretch. The tape will also remain in place for 48 hours. This will help control for the placebo effect of the taping procedure.
Psychosocial Support Group
SHAM COMPARATORParticipants in this group will receive elastic therapeutic tape applied to unrelated regions of the body (e.g., shoulder, back, or intercostal muscles) not associated with the surgical area. The purpose is to account for contextual or psychosocial effects of receiving an intervention. The tape will be applied without therapeutic intent for the surgical pain, and will stay in place for 48 hours.
Interventions
In this group, the same type of elastic tape used in the therapeutic group is applied to the skin near the surgical area, but without any stretch or therapeutic technique. The tape does not provide physical support or intended therapeutic effects. It is used to help researchers understand whether any improvements are due to the taping itself or simply from receiving an intervention. The tape remains in place for up to 48 hours and is applied by trained personnel using a standardized, non-therapeutic method.
In this group, elastic therapeutic tape is applied to body areas not directly related to the surgery, such as the shoulder, back, or rib area. The purpose is not to treat pain at the surgical site, but to simulate the experience of receiving a physical intervention. This approach helps researchers understand the potential impact of attention, expectation, or psychological support related to being part of a study. The tape is applied gently without therapeutic intent and stays on for up to 48 hours
Elastic therapeutic taping is a non-invasive method that uses a specially designed elastic cotton tape applied directly to the skin. In this study, it is used to support pain management after open-heart surgery (CABG via sternotomy). The tape is applied near the surgical site to gently lift the skin, which may help reduce pain, improve circulation, and support healing. The application is done by a trained physiotherapist following a standardized taping protocol. The tape remains on the skin for up to 48 hours.
Eligibility Criteria
You may qualify if:
- Age between 18 and 75 years
- Undergoing elective coronary artery bypass graft (CABG) surgery via sternotomy
- Able to understand and communicate effectively
- Willing to provide informed consent
You may not qualify if:
- Presence of dermatological conditions or open wounds in the sternotomy area
- History of allergy to elastic therapeutic tape or adhesive materials
- Diagnosis of neurological or psychiatric conditions that may affect pain perception
- Currently taking medications that significantly alter pain sensitivity (e.g., neuropathic pain medications)
- Participation in another interventional clinical study within the past 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bolu Abant Izzet Baysal University
Bolu, Bolu, 14030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 25, 2025
First Posted
April 4, 2025
Study Start
January 22, 2025
Primary Completion
December 24, 2025
Study Completion
December 24, 2025
Last Updated
December 31, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- De-identified individual participant data will be made available beginning 6 months after publication of the primary results and will remain available for up to 3 years upon request.
- Access Criteria
- Researchers may request access to the de-identified individual participant data (IPD) and supporting documents (e.g., protocol, SAP, ICF, analytic code) by submitting a written proposal that includes a clear research question and analysis plan. Requests should be sent to the Principal Investigator via institutional email. All requests will be reviewed by the research team and relevant ethics committee. If approved, data will be shared under a formal data use agreement. Data will be provided through a secure, password-protected digital platform.
Individual participant data (de-identified) that underlie the results reported in this study will be made available upon reasonable request from qualified researchers, following publication. Data will be shared through institutional approval processes in accordance with ethical guidelines.